MOTIVATional intErviewing to Improve Self-care in Heart Failure Patients (MOTIVATE-HF)

February 24, 2021 updated by: Ercole Vellone, University of Rome Tor Vergata

MOTIVATional intErviewing to Improve Self-care in Heart Failure Patients (MOTIVATE-HF): Study Protocol of a Three-arm Multicenter Randomized Controlled Trial

The aims of this study will be to evaluate the effect of motivational interviewing (MI) to improve self-care in heart failure (HF) patients and caregiver contributions to HF self-care. Also this study will evaluate the effect of MI on the following secondary outcomes: In HF patients: HF somatic symptom perception, generic and specific quality of life, anxiety and depression, sleep quality, mutuality with caregiver, hospitalizations, use of emergency services, and mortality; In caregivers: generic quality of life, anxiety and depression, mutuality with patient, preparedness, social support and sleep quality.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

510

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rome, Italy, 00135
        • University of Rome Tor Vergata

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

Diagnosis of HF (for patient), New York Heart Association (NYHA) functional class II- IV (for patient), Inadequate self-care assessed with the Self-Care Heart Failure Index (for patient), Being the informal caregiver of the patients (for caregiver).

Exclusion criteria:

Severe cognitive impairment evaluated with the Six-item screener (for patient), Acute coronary syndrome during the last three months (for patient), Living in a residential settings (e.g., nursing home) (for patient), Patients not willing to participate in the study (for caregiver).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Motivational interviewing only for patients
In this arm the interventions will be delivered only to patients
The intervention will consist of a brief session of motivational interviewing (MI) performed by a trained nurse. During MI, the interventionist will address one or two aspects of self-care that the participants want to address. After this first intervention, the same interventionist will contact the participant by telephone to improve the first intervention and provide further support as needed. These telephone contact will be done three times at two week intervals following the first intervention (for a total of two months). Patients and caregivers that receive the intervention also will be given informational material on HF management that is consistent with international guidelines.
Experimental: Motivational interviewing to patients and caregivers
In this arm the interventions will be delivered both to patients and caregivers
The intervention will consist of a brief session of motivational interviewing (MI) performed by a trained nurse. During MI, the interventionist will address one or two aspects of self-care that the participants want to address. After this first intervention, the same interventionist will contact the participant by telephone to improve the first intervention and provide further support as needed. These telephone contact will be done three times at two week intervals following the first intervention (for a total of two months). Patients and caregivers that receive the intervention also will be given informational material on HF management that is consistent with international guidelines.
No Intervention: Control group
This Group will receive the usual care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-care Maintenance in Patients
Time Frame: 3 months from the intervention
Self-care in HF patients will be measured with the Self-Care of HF Index V.6.2. Since this instrument has three separate scales, we considered as a primary outcome the score of the Self-care Maintenance scale. The Self-Care Maintenance scale has a score between 0 and 100 with higher score meaning better self-care. Self-Care Maintenance is considered adequate when the score is at least 70.
3 months from the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Burden of HF Symptoms in Patients
Time Frame: 3, 6, 9 and 12 months from the intervention
Burden of HF symptoms will be measured with the Heart Failure Somatic Perception Scale (HFSPS). The HFSPS has a range score between 0 and 90; the higher the score, the higher the burden of symptoms caused by heart failure.
3, 6, 9 and 12 months from the intervention
Patient and Caregiver Generic Physical and Mental Quality of Life
Time Frame: 3, 6, 9 and 12 months from the intervention
Patient and caregiver generic physical and mental quality of life will be assessed with the Short Form 12 (SF-12).
3, 6, 9 and 12 months from the intervention
Patient and Caregiver Anxiety and Depression
Time Frame: 3, 6, 9 and 12 months from the intervention
Patient and caregiver anxiety and depression will be evaluated with the Hospital Anxiety and Depression Scale
3, 6, 9 and 12 months from the intervention
Patient HF Specific Quality of Life
Time Frame: 3, 6, 9 and 12 months from the intervention
Patient HF specific quality of life will be evaluated with the Kansas City Cardiomyopathy Questionnaire
3, 6, 9 and 12 months from the intervention
Patient and Caregiver Quality of Nocturnal Sleep
Time Frame: 3, 6, 9 and 12 months from the intervention
We will use the Pittsburgh Sleep Quality Index
3, 6, 9 and 12 months from the intervention
Patient and Caregiver Mutuality
Time Frame: 3, 6, 9 and 12 months from the intervention
We will use the Mutuality Scale
3, 6, 9 and 12 months from the intervention
Caregiver Preparedness
Time Frame: 3, 6, 9 and 12 months from the intervention
Caregiver Preparedness will be evaluated with the Caregiver Preparedness Scale
3, 6, 9 and 12 months from the intervention
Caregiver Perceived Social Support
Time Frame: 3, 6, 9 and 12 months from the intervention
We will use the Multidimensional Scale of Perceived Social Support Scale
3, 6, 9 and 12 months from the intervention
Patient Hospitalizations
Time Frame: 3, 6, 9 and 12 months from the intervention
The number of patient hospitalizations will be measured asking the caregiver how many time the patient was hospitalized from at 3, 6, 9 and 12 months from the intervention.
3, 6, 9 and 12 months from the intervention
Use of Emergency Services
Time Frame: 3, 6, 9 and 12 months from the intervention
How many times the patient has used the emergency services will be evaluated by asking the caregiver how many time the patient used after 3, 6, 9 and 12 months from the intervention.
3, 6, 9 and 12 months from the intervention
Death
Time Frame: 3, 6, 9 and 12 months from the intervention
Death rates will be evaluated in the three arms of the study by caregiver interview at 3, 6, 9 and 12 months from the intervention.
3, 6, 9 and 12 months from the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2014

Primary Completion (Actual)

October 1, 2018

Study Completion (Actual)

October 1, 2018

Study Registration Dates

First Submitted

August 26, 2016

First Submitted That Met QC Criteria

September 3, 2016

First Posted (Estimate)

September 9, 2016

Study Record Updates

Last Update Posted (Actual)

March 17, 2021

Last Update Submitted That Met QC Criteria

February 24, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 121/13

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

In case there will be the possibility to share the data, this will be done after data de-identification

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

Clinical Trials on Motivational interviewing

3
Subscribe